Results 201 to 210 of about 65,159 (298)

NOTCH2NLC Repeat Expansions in Parkinsonian Disorders: Clinical and Neuroimaging Characteristics. [PDF]

Ann Clin Transl Neurol
Chiang HL, Jih KY, Hsiao CT, Chang FP, Chen JC, Liao YC, Wu YR, Lee YC.   +7 more
europepmc   +1 more source

Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders

, 2020
Vikas Kotagal, Martijn L.T.M. Müller, Daniel Kaufer, Robert A. Koeppe, Nicolaas I. Bohnen   +4 more
openalex   +1 more source

Subcutaneous Levodopa in Parkinson's Disease: A Systematic Review and Meta‐Analysis

European Journal of Neurology, Volume 33, Issue 2, February 2026.
ABSTRACT Background Many Parkinson's disease patients receiving oral levodopa/carbidopa experience a troublesome wearing off effect. Higher doses to mitigate OFF‐time are limited by adverse effects occurring at peak dopamine levels, particularly dyskinesia.
Matthew Burton, Duncan Marsden, Dhruv Harish, Peter Morris, Carl Heneghan, Ailsa Butler, David Nunan   +6 more
wiley   +1 more source

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders [PDF]

, 2015
Megan K. Herbert, Marjolein B. Aerts, Marijke Beenes, Niklas Norgren, Rianne A.J. Esselink, Bastiaan R. Bloem, H. Bea Kuiperij, Marcel M. Verbeek   +7 more
openalex   +1 more source

Atypical parkinsonian disorder

, 2015
Henry Knipe, Rohit Sharma, Daniel Bell
openaire   +1 more source

Purkinje Cell Loss in Essential Tremor: Collective Data From 215 Brains Over a 21‐Year Period

Annals of Clinical and Translational Neurology, Volume 13, Issue 1, Page 36-48, January 2026.
ABSTRACT Objective Essential tremor is a highly prevalent movement disorder. Pathological changes observed in essential tremor cerebella center around Purkinje cells and neighboring neuronal populations. Postmortem studies have variably, but not always, shown reduced Purkinje cell counts in essential tremor compared to controls.
Chloë A. Kerridge, Roberto S. Hernandez, Nora C. Hernandez, Phyllis L. Faust, Elan D. Louis   +4 more
wiley   +1 more source

Corticotropin-releasing hormone as a candidate biomarker for parkinsonian disorders. [PDF]

Brain Commun
Fernandes Gomes B, Kumar A, Ashton NJ, Hall S, Stomrud E, Smith R, Zetterberg H, Blennow K, Mattsson-Carlgren N, Hansson O.   +9 more
europepmc   +1 more source

Quantitative Assessment of Upper Limb Ataxia Using a Virtual Reality‐Based Evaluation System

Annals of Clinical and Translational Neurology, Volume 13, Issue 1, Page 180-192, January 2026.
ABSTRACT Objective Cerebellar ataxia impairs coordination and balance, reducing quality of life. Conventional clinical scales, including the Scale for the Assessment and Rating of Ataxia (SARA) and the International Cooperative Ataxia Rating Scale (ICARS), are widely used to assess ataxia but are limited by subjectivity and inter‐rater variability ...
Masayuki Sato, Takayuki Abe, Sho Aoki, Setsuki Tsukagoshi, Yasushi Yuminaka, Yoshio Ikeda   +5 more
wiley   +1 more source

RAB39B Related Parkinsonism in an Italian Family: A Unique Use of Advanced Therapies

Annals of Clinical and Translational Neurology, Volume 13, Issue 1, Page 204-208, January 2026.
ABSTRACT Parkinson's disease (PD) is a neurodegenerative disorder that may sometimes be caused by deleterious genetic variants. Among them, RAB39B polymorphisms are known as rare causes of early‐onset PD associated with intellectual disability (Waisman's syndrome).
Caterina Del Regno, Giovanni Ermanis, Christian Lettieri, Andrea Bernardini, Gaia Pellitteri, Enrico Belgrado, Elena Betto, Gian Luigi Gigli, David De Monte, Marco Domenico Scanni, Marco Mucchiut, Giuseppe Damante, Mariarosaria Valente, Francesco Janes   +13 more
wiley   +1 more source

A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders: A Consensus Statement. [PDF]

Neurol Clin Pract
Bruno MK, Dhall R, Duquette A, Haq IU, Honig LS, Lamotte G, Mari Z, McFarland NR, Montaser-Kouhsari L, Rodriguez-Porcel F, Shurer J, Siddiqui J, Spears CC, Wills AA, Diaz K, Golbe LI, as the Diagnosis and Treatment Working Group, CurePSP Center of Care (CoC) Network.   +17 more
europepmc   +1 more source